Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Advertising & Marketing

Sales

Legal & Regulatory

Acquisition & Integration

Goodwill impairment

Restructuring costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Teladoc

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002, by George Byron Brooks and Gary Wald and is headquartered in Purchase, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Teladoc reports solid Q4 growth, eyes revenue optimization strategies

Teladoc's Q4 performance showed revenue growth and margin focus, with BetterHelp contributing significantly to profitability.
The company's strategic focus on virtual care expansion and revenue optimization positions Teladoc for continued success in the healthcare market.
While facing internal restructuring challenges, Teladoc's emphasis on growth drivers and operational efficiency presents opportunities for future growth and market leadership.

Teladoc Health excels in Q1, eyes growth and efficiency

Teladoc Health's Q1 performance was strong, with revenue exceeding expectations.
The company is focused on efficiency, innovation, and driving value in virtual care.
BetterHelp segment showed growth and stability, with improving margins expected.
Opportunities exist to capitalize on ad pricing stability and consumer behavior trends.

Teladoc surpasses revenue expectations, focuses on innovation and growth

Teladoc's Q2 performance exceeded expectations, with strong revenue growth and improved margins in both segments. The company's strategic focus on whole-person care, weight management, and AI enhancements positions it well for future growth. Challenges include managing drug costs and private company valuations, while opportunities lie in virtual care demand and strategic M&A.
Teladoc's financial strength, commitment to innovation, and focus on efficiency improvements are key strengths driving its performance. The company's ability to navigate challenges and capitalize on opportunities in the evolving healthcare landscape underscores its resilience and growth potential.

Teladoc Health surpasses Q3 expectations, eyes margin expansion in '24

Teladoc Health's Q3 performance exceeded expectations, driven by revenue growth and margin improvements.
The company is focused on enhancing cost efficiencies, profitability, and driving margin expansion.
Stable pricing environment and strong client demand present opportunities for future growth.
Operational review and strategic initiatives position Teladoc for continued success in the healthcare sector.

Teladoc reports robust 2023 earnings, eyes growth amid marketing challenges

Teladoc delivered strong financial performance in 2023 with notable growth in adjusted EBITDA and revenue. The company faces challenges in BetterHelp marketing yields and delayed consumer engagement efforts.
However, Teladoc's strategic strengths lie in its long-term outlook for revenue growth, margin expansion, and cost-saving initiatives. Opportunities exist in optimizing sales force structure and capital deployment for future growth.
Overall, Teladoc's focus on profitability, growth optimization, and strategic capital allocation positions it well for sustained success in the telehealth industry.

Teladoc Health reports solid Q1 performance amidst revenue challenges

Teladoc Health's Q1 2024 performance showcased revenue growth in Integrated Care but challenges in BetterHelp segment revenue and margin management.
The company's financial strength, product portfolio, and cost initiatives position it well for growth opportunities and strategic market positioning.
Addressing challenges in ad spend management and focusing on international market efficiency are key to unlocking growth potential and improving financial performance.
Overall, Teladoc's performance, strengths, challenges, and opportunities reflect a dynamic landscape with strategic focus on sustainable growth and operational efficiency.

Teladoc Health reports Q2 revenue dip, EBITDA growth; addresses challenges

Teladoc Health's Q2 2024 performance showed mixed results with revenue decline but EBITDA growth. The company is leveraging strengths in patient safety and technology while addressing challenges in customer acquisition costs. Opportunities lie in operational efficiency, insurance coverage access, and international expansion.

Teladoc Health reports Q3 revenue decline but strategic growth

Teladoc Health's Q3 2024 performance reflects mixed results with revenue decline but strategic growth in the Integrated Care segment.
The company's focus on customer-centric strategies, technology, and clinical excellence positions it well for future success and market leadership.
Challenges in revenue decline and expense management require Teladoc Health to balance short-term financial performance with long-term growth objectives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002, by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in Purchase, NY.

The telehealth industry leader isn't buckling under increased competitive pressure.

Positive Earnings Pushed Teladoc Health Shares Higher on Thursday

Teladoc (TDOC) stock is getting a boost on Thursday following the release of its earnings report for the third quarter of 2021. The post TDOC Stock: 9 Reasons Why Teladoc Is Looking Healthy Today appeared first on InvestorPlace.

TDOC Stock: 9 Reasons Why Teladoc Is Looking Healthy Today

Teladoc Health Inc (NYSE: TDOC) reversed off its lows Thursday morning and is now surging higher after the company announced better-than-expected third-quarter financial results. Teladoc Health reported a quarterly earnings loss of 53 cents per share, which beat the estimate for a loss of 65 cents per share.

Why Teladoc Health Shares Are Surging Today

Teladoc Health's (TDOC) third-quarter results indicate improved revenues owing to higher access fees and visit fees, partly offset by elevated costs.

Teladoc Health (TDOC) Q3 Loss Narrower Than Expected, Down Y/Y

A broken stock does not mean a broken company.

This Is Why Teladoc Stock Rose Today

NextEra Energy

These two stocks are champions in industries that won't stop growing, regardless of what the economy or stock market does.

Have $2,000? 2 Market Crash-Ready Stocks to Buy Now

Etsy

2 Incredible Growth Stocks Long-Term Investors Should Buy More of This Week

Don't worry about the company's slowing revenue growth.

Why Teladoc Health's Prospects Look Better Than You Might Think

Teladoc Health, Inc. (TDOC) CEO Jason Gorevic on Q4 2021 Results - Earnings Call Transcript

eBay

Ford Motor Company

Late-day selling in the regular session brought indexes to their lows for the day, but Ford is up in late trading on Q3 numbers.

Investors Book Profits Late; Q3 Reports for Ford, eBay, Teladoc

Teladoc Health (NYSE:TDOC) reported its Q3 earnings results on Wednesday, October 27, 2021 at 04:00 PM. Here's what investors need to know about the announcement.

Recap: Teladoc Health Q3 Earnings

PURCHASE, NY, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the quarter ended September 30, 2021.

Teladoc Health Reports Third-Quarter 2021 Results

Telemedicine concern Teladoc Health Inc  (NYSE:TDOC) is taking a breather, last seen down 1.9% to trade at $138.65 this afternoon, just ahead of its third-quarter earnings report, which is due out after today's close.

Teladoc Stock Cools off Ahead of Earnings

ARK Innovation ETF

Coinbase

Skillz

The risk/reward ratio of these Cathie Wood stocks are quite negative, as their valuations are far too high. Sell them before the year ends.

4 Cathie Wood Stocks to Sell Before Year-End

ACADIA Pharma

Acadia Healthcare

Anthem

HCA Healthcare

MEDNAX

Tenet Healthcare

UnitedHealth Group

Vertex Pharmaceuticals

Factors like an aging populace and demand for products and services are likely to reflect on the Q3 results of ACAD, MD, ACHC and VRTX.

4 Healthcare Stocks to Top Q3 Estimates Amid Coronavirus Woes

Nearly 80 companies in our watch list reported earnings after markets closed Monday and before they opened again on Tuesday.

Earnings Previews: eBay, Ford, Teladoc

Teladoc has underperformed the market by a wide margin this year.

Is This Beaten-Down Tech Stock Worth Buying?

Stitch Fix

Analysts see significant upside for shareholders of these companies.

Want 100% Returns? Buy These Growth Stocks, Says Wall Street

Invitae

All eyes will be watching these ARK Invest holdings to see if they're working out as hoped.

3 Cathie Wood Stocks to Watch This Earnings Season

Beam Therapeutics

CRISPR Therapeutics

These stocks are risky, though, and ideally suited for aggressive investors.

3 Stocks Cathie Wood Is Buying That You Might Want to Consider Too

Fastly

Lemonade

The three stocks are regaining some of the massive losses they've endured so far in 2021.

Why Fastly, Teladoc, and Lemonade Stock Jumped Higher on Monday

Brookfield Renewable Partners

Adding $1,000 to These 3 Stocks Right Now Would Be a Brilliant Move

ChargePoint Holdings

Twenty-First Century Fox

Barrick Gold

Occidental Petroleum

Penn Entertainment

Shopify

High-upside stocks are always hot favorites of value investors. Currently, there are several such enterprises trading at great discounts.

These 7 High-Upside Stocks Belong in Your Portfolio

Twitter

Earnings season is well underway and these three stocks are worth watching.

3 Stocks to Keep an Eye on Ahead of Next Week's Earnings

Teladoc (TDOC) closed at $140.53 in the latest trading session, marking a +0.04% move from the prior day.

News for Teladoc Stock (TDOC)